XML 81 R61.htm IDEA: XBRL DOCUMENT v3.25.4
BUSINESS SEGMENT AND INTERNATIONAL OPERATION INFORMATION (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Segment information    
Net sales $ 480,144 $ 454,364
Cost of sales 132,420 129,676
Volume incentives 144,591 140,589
Selling, general and administrative 178,390 164,004
Operating income 24,743 20,095
Interest and other income, net 645 177
Interest expense (98) (146)
Foreign exchange gains (losses), net 4,522 (1,700)
Income from operations before provision for income taxes 29,812 18,426
Depreciation and amortization:    
Total depreciation and amortization 13,844 14,219
Property, plant and equipment, net    
Total property, plant and equipment, net 32,915 39,585
Operating Segments    
Segment information    
Net sales 480,144 454,364
Operating income 80,301 70,987
Depreciation and amortization:    
Total depreciation and amortization 13,844 14,219
Unallocated corporate selling, general and administrative expense    
Segment information    
Selling, general and administrative (55,558) (50,892)
General health | Operating Segments    
Segment information    
Net sales 192,122 183,882
Immune | Operating Segments    
Segment information    
Net sales 40,818 38,724
Cardiovascular | Operating Segments    
Segment information    
Net sales 81,635 81,700
Digestive | Operating Segments    
Segment information    
Net sales 124,368 111,744
Personal care | Operating Segments    
Segment information    
Net sales 23,267 17,803
Weight management | Operating Segments    
Segment information    
Net sales 17,934 20,511
Asia | Operating Segments    
Segment information    
Net sales 221,777 207,794
Cost of sales 48,484 48,557
Volume incentives 71,185 69,685
Selling, general and administrative 61,944 55,443
Operating income 40,164 34,109
Depreciation and amortization:    
Total depreciation and amortization 1,896 1,876
Asia | General health | Operating Segments    
Segment information    
Net sales 83,632 81,313
Asia | Immune | Operating Segments    
Segment information    
Net sales 14,438 12,052
Asia | Cardiovascular | Operating Segments    
Segment information    
Net sales 54,555 56,266
Asia | Digestive | Operating Segments    
Segment information    
Net sales 47,673 38,958
Asia | Personal care | Operating Segments    
Segment information    
Net sales 10,074 5,032
Asia | Weight management | Operating Segments    
Segment information    
Net sales 11,405 14,173
Europe | Operating Segments    
Segment information    
Net sales 93,133 84,837
Cost of sales 27,524 27,836
Volume incentives 37,359 33,758
Selling, general and administrative 20,203 18,577
Operating income 8,047 4,666
Depreciation and amortization:    
Total depreciation and amortization 99 93
Europe | General health | Operating Segments    
Segment information    
Net sales 39,794 36,631
Europe | Immune | Operating Segments    
Segment information    
Net sales 9,148 8,454
Europe | Cardiovascular | Operating Segments    
Segment information    
Net sales 10,805 9,265
Europe | Digestive | Operating Segments    
Segment information    
Net sales 24,601 22,748
Europe | Personal care | Operating Segments    
Segment information    
Net sales 5,813 5,397
Europe | Weight management | Operating Segments    
Segment information    
Net sales 2,972 2,342
North America | Operating Segments    
Segment information    
Net sales 143,611 138,849
Cost of sales 48,528 45,364
Volume incentives 29,485 29,773
Selling, general and administrative 34,736 32,793
Operating income 30,862 30,919
Depreciation and amortization:    
Total depreciation and amortization 11,801 12,204
North America | General health | Operating Segments    
Segment information    
Net sales 62,226 59,520
North America | Immune | Operating Segments    
Segment information    
Net sales 15,385 15,802
North America | Cardiovascular | Operating Segments    
Segment information    
Net sales 14,661 14,443
North America | Digestive | Operating Segments    
Segment information    
Net sales 41,804 39,325
North America | Personal care | Operating Segments    
Segment information    
Net sales 6,474 6,241
North America | Weight management | Operating Segments    
Segment information    
Net sales 3,061 3,518
Latin America and Other | Operating Segments    
Segment information    
Net sales 21,623 22,884
Cost of sales 7,884 7,918
Volume incentives 6,562 7,374
Selling, general and administrative 5,949 6,299
Operating income 1,228 1,293
Depreciation and amortization:    
Total depreciation and amortization 48 46
Latin America and Other | General health | Operating Segments    
Segment information    
Net sales 6,470 6,418
Latin America and Other | Immune | Operating Segments    
Segment information    
Net sales 1,847 2,416
Latin America and Other | Cardiovascular | Operating Segments    
Segment information    
Net sales 1,614 1,726
Latin America and Other | Digestive | Operating Segments    
Segment information    
Net sales 10,290 10,713
Latin America and Other | Personal care | Operating Segments    
Segment information    
Net sales 906 1,133
Latin America and Other | Weight management | Operating Segments    
Segment information    
Net sales 496 478
China    
Segment information    
Selling, general and administrative 16,800 14,500
United States    
Segment information    
Net sales 133,387 127,924
Property, plant and equipment, net    
Total property, plant and equipment, net 29,061 34,786
Taiwan    
Segment information    
Net sales 67,280 70,579
Japan    
Segment information    
Net sales 56,070 43,940
Korea    
Segment information    
Net sales 50,842 51,362
Other    
Segment information    
Net sales 172,565 160,559
Other    
Property, plant and equipment, net    
Total property, plant and equipment, net $ 3,854 $ 4,799